 |
 |
|
|
RESÚMENES AGOSTO 2008 |
Schizophrenia-Psychotic Disorders & Antipsychotics
(Haga un click en la información del journal
para acceder al resúmen)
5 – doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto gratuito en algunos países de la región iberoamericana
(algunos artículos requieren ir a la tabla de contenidos del
número actual de la revista)
5 -
Non-pharmacological management of antipsychotic-induced weight gain: systematic
review and meta-analysis of randomised controlled trials
Mario Álvarez-Jiménez, Sarah E. Hetrick, César
González-Blanch, John F. Gleeson, Patrick D. McGorry
The
British Journal of Psychiatry (2008) 193: 101-107
3 - Effectiveness of antipsychotic polypharmacy for
patients with treatment refractory schizophrenia: an open-label trial of
olanzapine plus risperidone for those who failed to respond to a sequential
treatment with olanzapine, quetiapine and risperidone
Takefumi Suzuki, Hiroyuki Uchida, Koichiro Watanabe, Shinichiro
Nakajima, Kensuke Nomura, Hiroyoshi Takeuchi, Akira Tanabe, Gohei Yagi, Haruo
Kashima
Human
Psychopharmacology: Clinical and Experimental. Volume 23 Issue
6, Pages 455 - 463
5 - Effects of warm-supplementing kidney yang (WSKY)
capsule added on risperidone on cognition in chronic schizophrenic patients: a
randomized, double-blind, placebo-controlled, multi-center clinical trial
Zhen-hua Chen, Gao-hua Wang, Xiao-ping Wang, Ren-yun Chen, Hui-lin Wang,
Ming-hua Yang, Yun-xiang Huo, Hong-bing Mei
Human
Psychopharmacology: Clinical and Experimental. Volume 23 Issue
6, Pages 465 - 470
3! - Pyridoxal Plasma Level in Schizophrenic and
Schizoaffective Patients With and Without Tardive
Dyskinesia
Miodownik, Chanoch; Meoded, Aviel; Libov, Igor;
Bersudsky, Yuly; Sela, Ben-Ami; Lerner,
Clinical
Neuropharmacology. 31(4):197-203, July/August 2008
3 - Neurocognitive Effects of Ziprasidone and Related
Factors in Patients With Chronic Schizophrenia
Undergoing Usual Care: A 12-Month, Open-Label, Flexible-Dose, Naturalistic
Observational Trial
Gibel, Anatoly; Ritsner, Michael S
Clinical Neuropharmacology. 31(4):204-220, July/August 2008
3 - Brain
and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An
[18F]Fallypride PET Study
Gerhard Gründer, Christine Fellows, Hildegard Janouschek,
Tanja Veselinovic, Christian Boy, Anno Bröcheler, Katrin M. Kirschbaum, Sandra
Hellmann, Katja M. Spreckelmeyer, Christoph Hiemke, Frank Rösch, Wolfgang M.
Schaefer, and Ingo Vernaleken
Am J
Psychiatry 2008; 165:988-995
5 - Selective
Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for
Schizophrenia
Anantha Shekhar, William Z. Potter, Jeffrey Lightfoot, John
Lienemann, Sanjay Dubé, Craig Mallinckrodt, Frank P. Bymaster, David L.
McKinzie, and Christian C. Felder
Am J
Psychiatry 2008; 165:1033-1039
5 - Initial
Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
Robert Freedman, Ann Olincy, Robert W. Buchanan, Josette G.
Harris, James M. Gold, Lynn Johnson, Diana Allensworth, Alejandrina
Guzman-Bonilla, Bettye Clement, M. Patricia Ball, Jay Kutnick, Vicki Pender,
Laura F. Martin, Karen E. Stevens, Brandie D. Wagner, Gary O. Zerbe, Ferenc
Soti, and William R. Kem
Am J
Psychiatry 2008; 165:1040-1047
3! - Adequacy
of Medical Treatment Among Older Persons With Schizophrenia
Ipsit V. Vahia, Shilpa Diwan, Azziza O. Bankole, Michelle
Kehn, Mohammed Nurhussein, Paul Ramirez, and Carl I. Cohen
Psychiatr
Serv 59:853-859, August 2008
5 - Estrogen
in Severe Mental Illness. A Potential New Treatment Approach
Jayashri Kulkarni,
Anthony de Castella, Paul B. Fitzgerald, Caroline T. Gurvich, PhD; Michael
Bailey, Cali Bartholomeusz, Henry Burger
Arch
Gen Psychiatry. 2008;65(8):955-960
GRATIS 3 - Allosteric modulation of the
muscarinic M4 receptor as an approach to treating schizophrenia
W. Y. Chan, D. L. McKinzie, S. Bose, S. N.
Mitchell, J. M. Witkin,
R. C. Thompson, A. Christopoulos, S. Lazareno, N. J. M.
Birdsall, F. P.
Bymaster, and C. C. Felder
PNAS August 5, 2008 vol. 105 no. 31 10978-10983
3! - Risk of discontinuation of risperidone after exposure
to potentially interacting drugs: A nested case-control study in patients with
schizophrenia
K. Jack Ishak, Ye Tan, Jennifer Glass, Doanh Luong and J. Jaime Caro
Clinical Therapeutics. Volume 30, Issue 7, July 2008, Pages 1251-1263
5 - N-Acetyl
Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind,
Randomized, Placebo-Controlled Trial
Michael Berk, David Copolov, Olivia Dean,
Kristy Lu, Sue Jeavons, Ian Schapkaitz, Murray Anderson-Hunt, Fiona Judd, Fiona
Katz, Paul Katz, Sean Ording-Jespersen, John Little, Philippe Conus, Michel
Cuenod, Kim Q. Do and Ashley I. Bush
Biological Psychiatry. Volume 64, Issue 5, 1 September 2008, Pages
361-368
3! - Genetic correlates of
olanzapine-induced weight gain in schizophrenia subjects from north
Vibhuti
Srivastava
, Smita N Deshpande, Vishwajit L Nimgaonkar,
Bernard Lerer & BK Thelma
Pharmacogenomics. August 2008, Vol. 9, No. 8, Pages 1055-1068
3 - Chlorpromazine attenuates pancreatic β-cell function and mass through IRS2 degradation,
while exercise partially reverses the attenuation
S. Park, SM
Hong, JE Lee, SR Sung, SH Kim
Journal
of Psychopharmacology, Vol. 22, No. 5, 522-531 (2008)
3! - A prospective study of glycaemic status in
anti-psychotic-treated patients
P.
Mackin, D. Bishop, HM Watkinson, IN Ferrie
Journal of Psychopharmacology, Vol. 22, No. 5, 563-566
(2008)
3 - Antipsychotic Medication Utilization Trends Among
Min Yang, Jamie C Barner, Kenneth
A Lawson, Karen L Rascati, James P Wilson, M Lynn Crismon, Jason Worchel,
Cynthia A Mascarenas
The Annals of Pharmacotherapy:
Vol. 42, No. 9, pp. 1229-1238
3!
- Antipsychotics and Diabetes: An Age-Related Association
Ariel Hammerman, Jacob Dreiher, Shmuel H Klang, Hanan Munitz, Arnon D
Cohen, Margalit Goldfracht
The Annals of Pharmacotherapy:
Vol. 42, No. 9, pp. 1316-1322
3 - Is
the Defined Daily Dose system a reliable tool for standardizing antipsychotic
dosages?
Nose, Michela; Tansella, Michele; Thornicroft,
Graham; Schene, Aart; Becker, Thomas; Veronese, Antonio; Leese, Morven; Koeter,
Maarten; Angermeyer, Matthias; Barbui, Corrado
International
Clinical Psychopharmacology. 23(5):287-290, September 2008
3 -
SNAP-25 gene polymorphisms and weight gain in schizophrenic patients
Richard Musil, Ilja Spellmann,
Michael Riedel, Sandra Dehning, Anette Douhet, Katja Maino, Peter Zill, Norbert
Müller, Hans-Jürgen Möller and Brigitta Bondy
Journal of
Psychiatric Research. Volume 42, Issue 12,
October 2008, Pages 963-970
3! - Impact of duration of untreated psychosis on
pre-treatment, baseline, and outcome characteristics in an epidemiological
first-episode psychosis cohort
Benno G. Schimmelmann, Christian
G. Huber, Martin Lambert, Sue Cotton, Patrick D. McGorry and Philippe Conus
Journal
of Psychiatric Research. Volume 42, Issue 12,
October 2008, Pages 982-990
3! - Persistent effects of mifepristone (RU-486) on
cortisol levels in bipolar disorder and schizophrenia
Peter Gallagher, Stuart Watson, Cordelia
Elizabeth Dye, Allan H. Young and
Journal
of Psychiatric Research. Volume 42, Issue 12,
October 2008, Pages 1037-1041
3! - Impact of Cannabis and Other Drugs on Age at Onset of
Psychosis
Ana González-Pinto,
Patricia Vega, Berta Ibáñez, Fernando Mosquera, Sara Barbeito, Miguel
Gutiérrez, Sonia Ruiz de Azúa, Iván Ruiz, and Eduard Vieta
J Clin Psychiatry 2008;69:1210-1216
3 - Monthly Administration of Long-Acting Injectable
Risperidone and Striatal Dopamine D2 Receptor Occupancy for the
Management of Schizophrenia
Hiroyuki Uchida,
David C. Mamo, Shitij Kapur, Alain Labelle, Chekkera Shammi, Erik J. L.
Mannaert, Steve W. Mann, and Gary Remington
J Clin Psychiatry 2008;69:1281-1286
3 - Affective Traits in Schizophrenia and Schizotypy
William P. Horan, Jack J.
Blanchard, Lee Anna Clark and Michael F. Green
Schizophrenia
Bulletin 2008 34(5):856-874
3 - Mortality among chronic schizophrenic patients: A
prospective 14-year follow-up study of 150 schizophrenic patients
G. Loas, A. Azi, C. Noisette and V. Yon
L'Encéphale. Volume 34, Issue 1, January 2008, Pages 54-60
3 - Comparative evaluation of clinical practice
guidelines for the treatment of schizophrenia
D. Delessert, V. Pomini, F. Grasset and P.
Baumann
L'Encéphale.
Volume 34,
Issue 1, January 2008, Pages 93-100
3! - Acute maternal stress in pregnancy and
schizophrenia in offspring: a cohort prospective study
D
Malaspina, C Corcoran, K R Kleinhaus, M C Perrin,
S Fennig, D Nahon, Y Friedlander and
3! - The biphasic changes of
insulin secretion in schizophrenic patients treated with olanzapine
M L Lu, C
H Chen, H C Liu, P Y Chen, S H Yu, and C C Chiu
Journal of Psychopharmacology First
published on August 21, 2008
3 - Asenapine induces
differential regional effects on serotonin receptor subtypes
F I
Tarazi, T Moran-Gates, E H F Wong, B Henry, and M Shahid
Journal of Psychopharmacology First
published on August 21, 2008
GRATIS (require
registro previo) 4 - Direct
and indirect effects of paliperidone extended-release tablets on negative
symptoms of schizophrenia
Ibrahim Turkoz,
Cynthia A Bossie, Bryan Dirks, Carla M Canuso
Neuropsychiatric Disease and Treatment. ON-LINE EARLY, August 2008
3 - Who responds to aripiprazole in clinical practice? An
observational study of combination versus monotherapy
P.
Shajahan, A. MacRae, M. Bashir, M. Taylor
Journal of
Psychopharmacology, Vol. 22, No. 7, 778-783 (2008)
3 - Cortical and
Subcortical 5-HT2A Receptor Binding in Neuroleptic-Naive
First-Episode Schizophrenic Patients
David Erritzoe,
Hans Rasmussen, Klaus T Kristiansen, Vibe G Frokjaer,
Steven Haugbol, Lars Pinborg, William Baaré, Claus Svarer,
Jacob Madsen, Henrik Lublin, Gitte M Knudsen and Birte
Y Glenthoj
Neuropsychopharmacology (2008) 33,
2435–2441
3 - Proton
Magnetic Resonance Spectroscopy During Initial
Treatment With Antipsychotic Medication in Schizophrenia
Juan R Bustillo,
Laura M Rowland, Rex Jung, William M Brooks,
Clifford Qualls, Roger Hammond,
Neuropsychopharmacology (2008) 33,
2456–2466
3! -
Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis. A 1H-MRS Study
Gregor E Berger,
Stephen J Wood, R Mark Wellard, Tina M Proffitt,
Mirabel McConchie, G Paul Amminger, Graeme D Jackson,
Dennis Velakoulis, Christos Pantelis and Patrick D McGorry
Neuropsychopharmacology (2008) 33,
2467–2473
3 - The
Molecular and Cellular Neurobiology of Nicotine Abuse in Schizophrenia
A. Mobascher, G. Winterer
Pharmacopsychiatry 2008;
41: S51-S59
5 - Psychomotor and cognitive
effects of a single oral dose of talnetant (SB223412) in healthy volunteers
compared with placebo or haloperidol
M Liem-Moolenaar, FA Gray, SJ de Visser, KL Franson,
RC Schoemaker, JAJ Schmitt, AF Cohen, and JMA van Gerven
Journal of Psychopharmacology First
published on August 28, 2008
3 - Effects of quetiapine,
risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of human
neuronal and immune cells in vitro
A J
Schmidt, J C Krieg, H W Clement, U M Hemmeter, E Schulz, H Vedder, and P Heiser
Journal of Psychopharmacology First
published on August 28, 2008
GRATIS 3 - Costs and effects of paliperidone extended
release compared with alternative oral antipsychotic agents in patients with
schizophrenia in
Maria
Geitona, Hara Kousoulakou, Markos Ollandezos, Kostas Athanasakis, Sotiria Papanicolaou and Ioannis Kyriopoulos
Annals
of General Psychiatry 2008, 7:16
5 -
Ethnic heterogeneity in glucoregulatory function during treatment with atypical
antipsychotics in patients with schizophrenia
Marilyn Ader, W. Timothy Garvey, Lawrence S.
Phillips, Charles B. Nemeroff, Georges Gharabawi, Ramy Mahmoud, Andrew
Greenspan, Sally A. Berry, Dominique L. Musselman, Jacqueline Morein, Young
Zhu, Lian Mao and Richard N. Bergman
Journal of Psychiatric Research. Volume 42, Issue 13, October 2008, Pages 1076-1085
3 - REM sleep EEG spectral analysis in patients with
first-episode schizophrenia
Julie Poulin, Emmanuel Stip and Roger Godbout
Journal of Psychiatric Research. Volume 42, Issue 13, October 2008, Pages 1086-1093
3 -
Drugs for men and women — How important is gender as a
risk factor for TdP?
Susan J. Coker
Pharmacology & Therapeutics. Volume 119, Issue 2, August 2008, Pages 186-194
GRATIS 3! - Diabetes mellitus during pregnancy and increased risk of schizophrenia in
offspring: a review of the evidence and putative mechanisms
Ryan J. Van Lieshout, Lakshmi P. Voruganti
J Psychiatry Neurosci 2008;33(5):395–404
GRATIS 3 - Tratamiento de la
Diskinesia Tardia
Maria Anahi Brizuela
Alcmeon,
Año XVII, Vol. 15, Nº 1, septiembre de 2008, págs. 50 a 81
| Regresar a RESÚMENES AGOSTO 2008 |